secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0001477449-24-000157
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc Health names Chuck Divita as CEO effective June 10, 2024
----------------------------------------------------------------

- Charles Divita appointed CEO and board member; Mala Murthy returns to CFO role.
- Divita previously EVP Commercial Markets at GuideWell/Florida Blue, overseeing $23B in revenue.
- New-hire equity award valued at ~$15M: 939,849 PSUs and 469,924 RSUs; base salary $800,000.
- Company amended 2023 Inducement Plan, increasing reserved shares by 4M to 4.5M for CEO grants.
- Mala Murthy's severance agreement amended to provide two years of enhanced severance protections.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000147744924000157/0001477449-24-000157-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000147744924000157/tdoc-20240605.htm
  HTML page:      https://secwatch.observer/filing/0001477449-24-000157

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer